Evidence map›Paper›PMID 22493429›Full record

ArticleThe Journal of biological chemistry2012

Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Theodora E Danciu, Sergey Chupreta, Osvaldo Cruz, Jennifer E Fox, Malcolm Whitman, Jorge A Iñiguez-Lluhí

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Targeting the Exonic CircularResearch (Washington, D.C.) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. International journal of molecular sciences · 2020
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Theodora E DanciuDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan 48109, USA. tdanciu@umich.edu
Sergey Chupreta
Osvaldo Cruz
Jennifer E Fox
Malcolm Whitman
Jorge A Iñiguez-Lluhí
University of Michigan–Ann Arbor · USHarvard University · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
The Role of FoxC1 in BMP-Mediated Msx2 InductionK22DE016614 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DANCIU, THEODORA E · 2005 to 2009
$665k
Regulation of nuclear receptor function through SUMO ModificationR56DK061656 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI INIGUEZ LLUHI, JORGE A · 2008 to 2008
$77k
NIDCR NIH HHS K22 DE016614NIDCR NIH HHS K22DE016614NIDDK NIH HHS P60 DK020572NIDDK NIH HHS P60 DK20572NIDDK NIH HHS R56 DK061656
6 · The paper itself

Abstract

FOXC1 and FOXC2 are forkhead transcription factors that play essential roles during development and physiology. Despite their critical role, the mechanisms that regulate the function of these factors remain poorly understood. We have identified conserved motifs within a previously defined N-terminal negative regulatory region of FOXC1/C2 that conforms to the definition of synergy control or SC motifs. Because such motifs inhibit the activity of transcription factors by serving as sites of post-translational modification by small ubiquitin-like modifier (SUMO), we have examined whether FOXC1/C2 are targets of SUMOylation and probed the functional significance of this modification. We find that endogenous FOXC1 forms modified by SUMO2/3 can be detected. Moreover, in cell culture, all three SUMO isoforms are readily conjugated to FOXC1 and FOXC2. The modification can be reconstituted in vitro with purified components and can be reversed in vitro by treatment with the SUMO protease SENP2. SUMOylation of FOXC1 and FOXC2 occurs primarily on one consensus synergy control motif with minor contributions of a second, more degenerate site. Notably, although FOXC1 is also phosphorylated at multiple sites, disruption of sites immediately downstream of the SC motifs does not influence SUMOylation. Consistent with a negative functional role, SUMOylation-deficient mutants displayed higher transcriptional activity when compared with wild type forms despite comparable protein levels and subcellular localization. Thus, the findings demonstrate that SC motifs mediate the inhibitory function of this region by serving as sites for SUMOylation and reveal a novel mechanism for acute and reversible regulation of FOXC1/C2 function.

Indexed as

Base SequenceBlotting, WesternCell LineDNA PrimersFluorescent Antibody TechniqueForkhead Transcription FactorsGene Expression Regulation, DevelopmentalHumansPhosphorylationSmall Ubiquitin-Related Modifier ProteinsDNA PrimersForkhead Transcription FactorsFOXC1 protein, humanmesenchyme fork head 1 proteinSmall Ubiquitin-Related Modifier Proteins

Identifiers

PMID22493429
PMCPMC3365760
OpenAlexW2147035936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.